Market Cap 28.09M
Revenue (ttm) 5.21M
Net Income (ttm) -22.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -429.75%
Debt to Equity Ratio 0.06
Volume 96,300
Avg Vol 197,148
Day's Range N/A - N/A
Shares Out 6.88M
Stochastic %K 4%
Beta 1.38
Analysts Sell
Price Target $34.50

Company Profile

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat va...

Industry: Biotechnology
Sector: Healthcare
Phone: 737 255 7194
Fax: 210 974 6901
Address:
6420 LEVIT GREEN BOULEVARD, SUITE 210, Houston, United States
TheVirus0011
TheVirus0011 Jun. 25 at 1:04 AM
$PSTV I have a feeling it's going to rise within the next 15 days.
0 · Reply
Investor1862
Investor1862 Jun. 24 at 10:18 PM
$PSTV below 1 by end of year, another reverse split to follow. Con artists.
0 · Reply
flywithfitz81
flywithfitz81 Jun. 24 at 7:59 PM
0 · Reply
Jc237
Jc237 Jun. 24 at 3:17 PM
$PSTV they have announced several great updates over the past year putting a foundation down, I will jump back in when They actually start selling cnside or positive test results.
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 2:59 PM
$PSTV 2.92 looking possible
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 2:47 PM
$PSTV granny went all in
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 2:02 PM
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 1:00 PM
0 · Reply
Igotgame1
Igotgame1 Jun. 24 at 12:46 PM
$PSTV turnaround
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 3:15 AM
0 · Reply
Latest News on PSTV
Plus Therapeutics Registration statement: Registration filing

Jun 5, 2026, 8:00 AM EDT - 19 days ago

Plus Therapeutics Registration statement: Registration filing


Plus Therapeutics Registration statement: Registration filing

Jun 2, 2026, 8:00 AM EDT - 22 days ago

Plus Therapeutics Registration statement: Registration filing


Plus Therapeutics files $100M mixed securities shelf

2026-06-02T10:13:30.000Z - 22 days ago

Plus Therapeutics files $100M mixed securities shelf


Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)

2026-05-15T20:11:34.000Z - 5 weeks ago

Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)


Plus Therapeutics Earnings release: Q1 2026

May 15, 2026, 4:00 PM EDT - 5 weeks ago

Plus Therapeutics Earnings release: Q1 2026


Plus Therapeutics Quarterly report: Q1 2026

May 15, 2026, 4:00 PM EDT - 5 weeks ago

Plus Therapeutics Quarterly report: Q1 2026


Plus Therapeutics Transcript: AGM 2026

May 14, 2026, 9:00 AM EDT - 5 weeks ago

Plus Therapeutics Transcript: AGM 2026


Plus Therapeutics Slides: FY 2026

May 8, 2026, 7:00 AM EDT - 6 weeks ago

Plus Therapeutics Slides: FY 2026


Plus Therapeutics Appoints Eric J. Daniels, M.D.

Apr 9, 2026, 7:30 AM EDT - 2 months ago

Plus Therapeutics Appoints Eric J. Daniels, M.D.


Plus Therapeutics granted Orphan Drug Designation for Reyobiq

2026-04-08T11:39:50.000Z - 2 months ago

Plus Therapeutics granted Orphan Drug Designation for Reyobiq


Plus Therapeutics Inc (USA) trading halted, news pending

2026-04-01T23:50:16.000Z - 3 months ago

Plus Therapeutics Inc (USA) trading halted, news pending


Plus Therapeutics Proxy statement: Proxy filing

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Plus Therapeutics Proxy statement: Proxy filing


Plus Therapeutics Proxy statement: Proxy filing

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Plus Therapeutics Proxy statement: Proxy filing


Plus Therapeutics announces 1-for-25 reverse stock split

2026-03-31T11:38:10.000Z - 3 months ago

Plus Therapeutics announces 1-for-25 reverse stock split


Plus Therapeutics’ CNSide assay may reduce healthcare costs

2026-03-19T12:01:47.000Z - 3 months ago

Plus Therapeutics’ CNSide assay may reduce healthcare costs


Plus Therapeutics reports Q4 EPS (29c), consensus (4c)

2026-03-12T21:05:16.000Z - 3 months ago

Plus Therapeutics reports Q4 EPS (29c), consensus (4c)


Plus Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 3 months ago

Plus Therapeutics Earnings release: Q4 2025


Plus Therapeutics Annual report: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 3 months ago

Plus Therapeutics Annual report: Q4 2025


Plus Therapeutics initiated with a Buy at Lake Street

2026-02-03T13:40:32.000Z - 5 months ago

Plus Therapeutics initiated with a Buy at Lake Street


Plus Therapeutics Transcript: Business update

Jan 22, 2026, 9:00 AM EST - 5 months ago

Plus Therapeutics Transcript: Business update


Plus Therapeutics Press release: Business update

Jan 22, 2026, 9:00 AM EST - 5 months ago

Plus Therapeutics Press release: Business update


Plus Therapeutics Slides: Business update

Jan 22, 2026, 9:00 AM EST - 5 months ago

Plus Therapeutics Slides: Business update


Plus Therapeutics announces anticipated milestones for FY26

2026-01-22T12:50:20.000Z - 5 months ago

Plus Therapeutics announces anticipated milestones for FY26


Plus Therapeutics Registration statement: Registration Filing

Jan 9, 2026, 7:00 AM EST - 5 months ago

Plus Therapeutics Registration statement: Registration Filing


Plus Therapeutics Quarterly report: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 8 months ago

Plus Therapeutics Quarterly report: Q3 2025


Plus Therapeutics Earnings release: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 8 months ago

Plus Therapeutics Earnings release: Q3 2025


Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch

Oct 21, 2025, 7:30 AM EDT - 8 months ago

Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch


Plus Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 11 months ago

Plus Therapeutics Quarterly report: Q2 2025


Plus Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 4:00 PM EDT - 11 months ago

Plus Therapeutics Earnings release: Q2 2025


Plus Therapeutics Registration statement: Registration Filing

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Plus Therapeutics Registration statement: Registration Filing


Plus Therapeutics Proxy statement: Proxy Filing

Aug 1, 2025, 8:00 AM EDT - 11 months ago

Plus Therapeutics Proxy statement: Proxy Filing


Plus Therapeutics Proxy statement: Proxy Filing

Jul 21, 2025, 8:00 AM EDT - 1 year ago

Plus Therapeutics Proxy statement: Proxy Filing


Plus Therapeutics Proxy statement: Proxy Filing

Jul 11, 2025, 8:00 AM EDT - 1 year ago

Plus Therapeutics Proxy statement: Proxy Filing


Plus Therapeutics Transcript: Business Update

Jun 26, 2025, 9:00 AM EDT - 1 year ago

Plus Therapeutics Transcript: Business Update


Plus Therapeutics Press release: Business Update

Jun 26, 2025, 9:00 AM EDT - 1 year ago

Plus Therapeutics Press release: Business Update


TheVirus0011
TheVirus0011 Jun. 25 at 1:04 AM
$PSTV I have a feeling it's going to rise within the next 15 days.
0 · Reply
Investor1862
Investor1862 Jun. 24 at 10:18 PM
$PSTV below 1 by end of year, another reverse split to follow. Con artists.
0 · Reply
flywithfitz81
flywithfitz81 Jun. 24 at 7:59 PM
0 · Reply
Jc237
Jc237 Jun. 24 at 3:17 PM
$PSTV they have announced several great updates over the past year putting a foundation down, I will jump back in when They actually start selling cnside or positive test results.
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 2:59 PM
$PSTV 2.92 looking possible
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 2:47 PM
$PSTV granny went all in
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 2:02 PM
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 1:00 PM
0 · Reply
Igotgame1
Igotgame1 Jun. 24 at 12:46 PM
$PSTV turnaround
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 24 at 3:15 AM
0 · Reply
Duke2021
Duke2021 Jun. 23 at 5:54 PM
$PSTV This turd will finish red
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 23 at 2:40 PM
$PSTV marky Marc I c u
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 23 at 1:49 PM
$PSTV Marc just sign my BID and go to the Bahamas
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 23 at 1:48 PM
$PSTV ok ok Marc I forgive u for now
0 · Reply
Washingtonstate
Washingtonstate Jun. 23 at 1:45 PM
1 · Reply
plustherapeutics
plustherapeutics Jun. 23 at 1:26 PM
$PSTV announces that management will host a business update conference call and webcast on Tuesday, June 30, 2026, at 8:30 a.m. Eastern Time. Full press release here: https://ir.plustherapeutics.com/news-releases/news-release-details/plus-therapeutics-provide-business-update-call-june-30-2026
0 · Reply
jamesownsu
jamesownsu Jun. 23 at 12:20 PM
$AMOD $CENN $CUPR $PSTV Cenn isng going to be low float much longer. Wang diluting tyd fuk out of this right now😂
0 · Reply
Bolleh
Bolleh Jun. 23 at 12:16 PM
$PSTV Business Update Call - might be some great updates, might be nothing at all. Gonna be interesting listening to it nontheless, but I don't expect anything other than just an update without any major news.
1 · Reply
focafoca99
focafoca99 Jun. 23 at 11:46 AM
$PSTV hosts a business update call on June 30 to discuss its CNSide diagnostic launch and Reyobiq development. https://www.rapidticker.com/news/pstv-plus-therapeutics-to-provide-business-a9158b
0 · Reply
Lehameri
Lehameri Jun. 23 at 10:59 AM
$PSTV sucks to see this retesting what i might be lows. Its been such a roller coaster. "We're going up." "Oh no, we're going down." "Wait, wait up?" "Oh, right."But it does make me happy for the sls crew that their patience is paying off. So it makes hopeful.
0 · Reply
Longintactandinminent
Longintactandinminent Jun. 23 at 10:54 AM
$PSTV intact
0 · Reply
Marketmoverjoe
Marketmoverjoe Jun. 23 at 10:40 AM
$PSTV the daily 4% dilution. it's gonna be a great day, folks.
0 · Reply